|
Delayed
Sao Paulo
07:36:00 20/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 64.98 BRL | +0.25% |
|
+4.44% | +13.34% |
| 19/10 | Gilead Sciences, Inc. Presents New Findings From Its HIV And Antiviral Research And Development Programs At IDWeek 2026 | CI |
| 19/10 | Gilead's pill succeeds in mid-stage bowel disease trial | RE |
| Market Cap | 19TCr 95TCr 17TCr 16TCr 14TCr 27TCr 17,98000Cr 27TCr 1,87900Cr 74TCr 9,40900Cr 71TCr 70TCr 30,01700Cr | P/E 2026 * |
-44.7x | P/E 2027 * | 19x |
|---|---|---|---|---|---|
| Enterprise Value | 21TCr 1,05900Cr 19TCr 17TCr 16TCr 30TCr 19,99500Cr 30TCr 2,08900Cr 82TCr 10,46400Cr 79TCr 78TCr 33,38100Cr | EV / Sales 2026 * |
6.87x | EV / Sales 2027 * | 6.19x |
| Free-Float |
99.89% | Yield 2026 * |
2.15% | Yield 2027 * | 2.19% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +0.25% | ||
| 1 week | +4.44% | ||
| Current month | -1.46% | ||
| 1 month | +1.04% | ||
| 3 months | +14.71% | ||
| 6 months | +22.26% | ||
| Current year | +13.34% |
| 1 week | 63.84 |  | 67.38 |
| 1 month | 59.28 | | 67.38 |
| Current year | 52.08 | | 67.38 |
| 1 year | 52.08 | | 67.38 |
| 3 years | 27.26 | | 67.38 |
| 5 years | 22.04 | | 67.38 |
| 10 years | 17.05 | | 67.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 01/03/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 01/11/2019 |
Keeley Wettan
CMP | Compliance Officer | - | 18/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 19/08/2016 |
| Director/Board Member | 73 | 01/01/2018 | |
Harish Manwani
BRD | Director/Board Member | 72 | 09/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.25% | +4.44% | - | - | 19TCr | |
| +3.57% | +10.07% | +58.72% | +119.61% | 1,10600Cr | |
| +1.92% | +4.02% | +33.50% | +69.03% | 61TCr | |
| +1.85% | +5.27% | +24.46% | +97.52% | 50TCr | |
| +2.58% | +8.37% | +38.71% | +63.14% | 37TCr | |
| +3.12% | +4.46% | +71.81% | +44.45% | 35TCr | |
| +1.85% | +6.04% | +21.47% | +49.17% | 29TCr | |
| +1.76% | +6.07% | +0.43% | +20.98% | 26TCr | |
| +2.52% | +5.53% | +43.63% | +56.26% | 23TCr | |
| +1.82% | +5.42% | +26.67% | +100.44% | 19TCr | |
| Average | +2.06% | +2.13% | +35.49% | +68.96% | 43.33TCr | |
| Weighted average by Cap. | +2.43% | +2.30% | +40.67% | +80.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.07TCr 15TCr 2.74TCr 2.54TCr 2.3TCr 4.32TCr 2,91100Cr 4.39TCr 30TCr 12TCr 1,52300Cr 12TCr 11TCr 4,86000Cr | 3.28TCr 16TCr 2.92TCr 2.71TCr 2.45TCr 4.61TCr 3,11100Cr 4.69TCr 33TCr 13TCr 1,62800Cr 12TCr 12TCr 5,19300Cr |
| Net income | -425.66Cr -2.14TCr -378.88Cr -351.15Cr -318.2Cr -598.01Cr -40TCr -608.02Cr -4.21TCr -1.66TCr -21TCr -1.6TCr -1.56TCr -67TCr | 1.03TCr 5.15TCr 913.98Cr 847.08Cr 767.59Cr 1.44TCr 97TCr 1.47TCr 10TCr 3.99TCr 51TCr 3.85TCr 3.77TCr 1,62400Cr |
| Net Debt | 2.13TCr 11TCr 1.89TCr 1.75TCr 1.59TCr 2.99TCr 2,01500Cr 3.04TCr 21TCr 8.27TCr 1,05500Cr 7.98TCr 7.81TCr 3,36400Cr | 1.36TCr 6.83TCr 1.21TCr 1.12TCr 1.02TCr 1.91TCr 1,29000Cr 1.95TCr 13TCr 5.3TCr 68TCr 5.11TCr 5TCr 2,15400Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | R$64.98 | +0.25% | 1 |
| 19/26/19 | R$64.82 | -1.50% | 2 |
| 16/26/16 | R$65.81 | -1.98% | 1,782 |
| 15/26/15 | R$67.14 | +4.22% | 5 |
| 14/26/14 | R$64.42 | +3.54% | 221 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
- GILD34 Stock
Select your edition
All financial news and data tailored to specific country editions
